Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases

Neurological Sciences

Volumn 34, Issue 5, 2013, Pages 647-653

  De Potter, Bruno ^a   De Meerleer, Gert ^a   De Neve, Wilfried ^a   Boterberg, Tom ^a   Speleers, Bruno ^a   Ost, Piet ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Brain metastases; HSRT; IMRT; WBRT

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BRAIN DAMAGE; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOFRACTIONATED FRAMELESS STEREOTACTIC RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; MALE; NEUROTOXICITY; OVERALL SURVIVAL; PRIMARY TUMOR; STEREOTACTIC TREATMENT; SURVIVAL; TREATMENT INDICATION; TREATMENT RESPONSE; TUMOR VOLUME; WHOLE BRAIN RADIOTHERAPY;

AGED; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84878018763     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1091-0     Document Type: Article

References (33)

1. Scoccianti S, Ricardi U (2011) Treatment of brain metastases: Review of phase III randomized controlled trials. Radiother Oncol 102(2):168-179 (epub 2011/10/15)
2. Soffietti R, Ducati A, Ruda R (2012) Brain metastases. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 105, pp 747-755 (epub 2012/01/11)
3. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745-751 (epub 1997/03/01)
4. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45(2):427-434 (epub 1999/09/16)
5. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17):1485-1489 (epub 1998/11/11)
6. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665-1672 (epub 2004/05/26)
7. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53(3):519-526 (epub 2002/06/14)
8. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1):45-68 (epub 2009/12/05)
9. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47(2):291-298 (epub 2000/05/10)
10. Powers WE, Tolmach LJ (1963) A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 197:710-711 (epub 1963/02/16)
11. Brenner DJ, Martel MK, Hall EJ (1991) Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. Int J Radiat Oncol Biol Phys 21(3):819-824 (epub 1991/08/01)
12. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81(1):18-24 (epub 2006/09/19)
13. Guckenberger M, Baier K, Guenther I, Richter A, Wilbert J, Sauer O et al (2007) Reliability of the bony anatomy in image-guided stereotactic radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 69(1):294-301 (epub 2007/08/21)
14. Withers HR, Thames HD Jr, Peters LJ (1983) A new isoeffect curve for change in dose per fraction. Radiother Oncol 1(2):187-191 (epub 1983/11/01)
15. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341-1346 (epub 1995/03/30)
16. Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase-II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277-1280
17. Khuntia D, Brown P, Li J, Mehta MP (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24(8):1295-1304 (epub 2006/03/10)
18. Aoki M, Abe Y, Hatayama Y, Kondo H, Basaki K (2006) Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys 64(2):414-418 (epub 2005/11/08)
19. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y (2009) Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 115(4):890-898 (epub 2009/01/10)
20. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29(2):134-141 (epub 2010/11/03)
21. Giubilei C, Ingrosso G, D'Andrea M, Benassi M, Santoni R (2009) Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases. J Neurooncol 91(2):207-212 (epub 2008/09/23)
22. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N et al (2003) Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56(3):793-800 (epub 2003/06/06)
23. Narayana A, Chang J, Yenice K, Chan K, Lymberis S, Brennan C et al (2007) Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 85(2-3):82-87 (epub 2006/12/15)
24. Rodrigues G, Eppinga W, Lagerwaard F, de Haan P, Haasbeek C, Perera F et al (2011) A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases. Radiother Oncol 102(2):180-186 (epub 2011/06/07)
25. Marchetti M, Milanesi I, Falcone C, De Santis M, Fumagalli L, Brait L et al (2011) Hypofractionated stereotactic radiotherapy for oligometastases in the brain: a single-institution experience. Neurol Sci 32(3):393-399 (epub 2011/01/15)
26. Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT (2005) Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 61(5):1460-1466 (epub 2005/04/09)
27. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5):1388-1395 (epub 2007/08/07)
28. Masi L, Casamassima F, Polli C, Menichelli C, Bonucci I, Cavedon C (2008) Cone beam CT image guidance for intracranial stereotactic treatments: comparison with a frame guided set-up. Int J Radiat Oncol Biol Phys 71(3):926-933 (epub 2008/06/03)
29. Boda-Heggemann J, Walter C, Rahn A, Wertz H, Loeb I, Lohr F et al (2006) Repositioning accuracy of two different mask systems-3D revisited: comparison using true 3D/3D matching with cone-beam CT. Int J Radiat Oncol Biol Phys 66(5):1568-1575 (epub 2006/11/28)
30. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C et al (2000) Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 47(3):603-608 (epub 2000/06/06)
31. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R et al (2007) Hypofractionated stereotactic radiotherapy for brain metastases-results from three different dose concepts. Strahlenther Onkol 183(11):625-630 (epub 2007/10/26)
32. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81(1):18-24 (epub 2006/09/19)
33. Lindvall P, Bergstrom P, Lofroth PO (2009) Tommy Bergenheim A. A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases. Acta Neurochir (Wien) 151(9):1053-1059 (epub 2009/04/25)